Colleen McIlvennan
Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 59 | 2024 | 561 | 11.830 |
Why?
| | Heart Failure | 82 | 2025 | 2093 | 9.250 |
Why?
| | Caregivers | 26 | 2024 | 940 | 4.550 |
Why?
| | Decision Making | 15 | 2023 | 950 | 2.020 |
Why?
| | Terminal Care | 10 | 2022 | 252 | 2.020 |
Why?
| | Palliative Care | 10 | 2024 | 819 | 1.520 |
Why?
| | Heart Transplantation | 8 | 2024 | 714 | 1.510 |
Why?
| | Quality of Life | 22 | 2024 | 3005 | 1.450 |
Why?
| | Ventricular Function, Left | 4 | 2020 | 515 | 1.080 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2023 | 375 | 1.000 |
Why?
| | Choice Behavior | 2 | 2020 | 171 | 0.980 |
Why?
| | Delivery of Health Care | 4 | 2023 | 949 | 0.940 |
Why?
| | Cardiology | 2 | 2019 | 279 | 0.930 |
Why?
| | Patient Care Team | 5 | 2024 | 664 | 0.910 |
Why?
| | Health Knowledge, Attitudes, Practice | 7 | 2024 | 1395 | 0.900 |
Why?
| | Humans | 102 | 2025 | 140898 | 0.840 |
Why?
| | Thrombosis | 3 | 2021 | 398 | 0.820 |
Why?
| | Heart Injuries | 1 | 2023 | 40 | 0.770 |
Why?
| | Stress, Psychological | 3 | 2021 | 1122 | 0.760 |
Why?
| | Physician-Patient Relations | 4 | 2024 | 580 | 0.760 |
Why?
| | Patient Participation | 7 | 2025 | 424 | 0.750 |
Why?
| | Emotions | 6 | 2023 | 575 | 0.740 |
Why?
| | Registries | 6 | 2024 | 2143 | 0.720 |
Why?
| | Middle Aged | 41 | 2025 | 34487 | 0.680 |
Why?
| | Patients | 3 | 2023 | 179 | 0.680 |
Why?
| | Substance Abuse Detection | 2 | 2025 | 105 | 0.660 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 156 | 0.650 |
Why?
| | Palliative Medicine | 2 | 2017 | 17 | 0.640 |
Why?
| | Patient Preference | 6 | 2024 | 203 | 0.640 |
Why?
| | Health Literacy | 3 | 2024 | 176 | 0.630 |
Why?
| | Delirium | 1 | 2021 | 105 | 0.620 |
Why?
| | Patient Readmission | 2 | 2015 | 707 | 0.600 |
Why?
| | Biomedical Research | 3 | 2020 | 680 | 0.590 |
Why?
| | Attitude to Death | 2 | 2016 | 69 | 0.580 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 371 | 0.570 |
Why?
| | Risk Assessment | 6 | 2020 | 3484 | 0.570 |
Why?
| | Coronavirus Infections | 2 | 2020 | 367 | 0.560 |
Why?
| | Aged | 32 | 2025 | 24666 | 0.560 |
Why?
| | Betacoronavirus | 2 | 2020 | 274 | 0.560 |
Why?
| | Male | 49 | 2025 | 69893 | 0.550 |
Why?
| | Qualitative Research | 9 | 2024 | 1525 | 0.540 |
Why?
| | Patient Acceptance of Health Care | 3 | 2020 | 876 | 0.530 |
Why?
| | Hospice Care | 3 | 2016 | 205 | 0.530 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2017 | 19 | 0.530 |
Why?
| | Female | 49 | 2025 | 75540 | 0.520 |
Why?
| | Surveys and Questionnaires | 9 | 2024 | 5931 | 0.520 |
Why?
| | Caliciviridae Infections | 1 | 2016 | 20 | 0.510 |
Why?
| | Hospital Records | 1 | 2016 | 10 | 0.510 |
Why?
| | Mexiletine | 1 | 2016 | 6 | 0.500 |
Why?
| | Amphetamine | 1 | 2016 | 37 | 0.490 |
Why?
| | Hospitalization | 5 | 2024 | 2261 | 0.490 |
Why?
| | Quality Improvement | 4 | 2021 | 1234 | 0.480 |
Why?
| | Cryosurgery | 1 | 2016 | 47 | 0.470 |
Why?
| | Physicians | 4 | 2020 | 928 | 0.470 |
Why?
| | Bereavement | 1 | 2016 | 57 | 0.470 |
Why?
| | Myocardial Infarction | 1 | 2023 | 1069 | 0.470 |
Why?
| | Adaptation, Psychological | 9 | 2024 | 678 | 0.470 |
Why?
| | Clinical Decision-Making | 2 | 2024 | 339 | 0.460 |
Why?
| | Transplant Recipients | 1 | 2016 | 181 | 0.440 |
Why?
| | Partial Thromboplastin Time | 1 | 2014 | 53 | 0.440 |
Why?
| | Patient-Centered Care | 4 | 2021 | 536 | 0.440 |
Why?
| | Heart Diseases | 2 | 2017 | 334 | 0.430 |
Why?
| | Tachycardia, Ventricular | 1 | 2016 | 175 | 0.430 |
Why?
| | Heart Ventricles | 4 | 2021 | 749 | 0.420 |
Why?
| | Adult | 29 | 2025 | 39134 | 0.420 |
Why?
| | Depression | 2 | 2021 | 1487 | 0.410 |
Why?
| | Treatment Outcome | 13 | 2024 | 11125 | 0.410 |
Why?
| | Stroke Volume | 4 | 2023 | 590 | 0.410 |
Why?
| | Advance Care Planning | 2 | 2017 | 223 | 0.410 |
Why?
| | Decision Support Techniques | 4 | 2020 | 429 | 0.400 |
Why?
| | Research Design | 1 | 2019 | 1104 | 0.400 |
Why?
| | Blood Coagulation | 1 | 2014 | 269 | 0.380 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1598 | 0.380 |
Why?
| | Substance-Related Disorders | 2 | 2025 | 1093 | 0.380 |
Why?
| | United States | 18 | 2025 | 15195 | 0.380 |
Why?
| | Attitude to Health | 1 | 2016 | 451 | 0.380 |
Why?
| | Drug Monitoring | 1 | 2016 | 398 | 0.380 |
Why?
| | Pandemics | 2 | 2020 | 1643 | 0.380 |
Why?
| | Informed Consent | 1 | 2014 | 187 | 0.370 |
Why?
| | Interviews as Topic | 4 | 2024 | 841 | 0.360 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1310 | 0.360 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2082 | 0.360 |
Why?
| | Anticoagulants | 2 | 2021 | 674 | 0.340 |
Why?
| | American Heart Association | 4 | 2024 | 296 | 0.330 |
Why?
| | Activities of Daily Living | 1 | 2014 | 425 | 0.320 |
Why?
| | Health Personnel | 2 | 2022 | 724 | 0.310 |
Why?
| | Program Development | 2 | 2023 | 364 | 0.280 |
Why?
| | Patient Reported Outcome Measures | 4 | 2024 | 437 | 0.270 |
Why?
| | Social Support | 3 | 2024 | 629 | 0.270 |
Why?
| | Patient Education as Topic | 3 | 2018 | 772 | 0.260 |
Why?
| | Risk Factors | 9 | 2021 | 10430 | 0.250 |
Why?
| | Withholding Treatment | 2 | 2016 | 77 | 0.230 |
Why?
| | Mental Health | 2 | 2023 | 753 | 0.230 |
Why?
| | Cost of Illness | 2 | 2020 | 310 | 0.230 |
Why?
| | Communication | 4 | 2024 | 948 | 0.230 |
Why?
| | Data Collection | 2 | 2019 | 651 | 0.220 |
Why?
| | Health Services Needs and Demand | 2 | 2024 | 282 | 0.220 |
Why?
| | Troponin | 1 | 2023 | 51 | 0.200 |
Why?
| | Cardiovascular Agents | 1 | 2024 | 156 | 0.190 |
Why?
| | Quality Assurance, Health Care | 1 | 2024 | 318 | 0.190 |
Why?
| | Hospital Mortality | 2 | 2016 | 923 | 0.170 |
Why?
| | Frailty | 1 | 2024 | 176 | 0.170 |
Why?
| | Guideline Adherence | 1 | 2025 | 553 | 0.170 |
Why?
| | Trust | 1 | 2022 | 144 | 0.170 |
Why?
| | Survival Rate | 3 | 2024 | 1962 | 0.160 |
Why?
| | Home Nursing | 1 | 2020 | 24 | 0.160 |
Why?
| | BK Virus | 1 | 2019 | 16 | 0.160 |
Why?
| | Retrospective Studies | 12 | 2025 | 16315 | 0.160 |
Why?
| | Thoracentesis | 1 | 2019 | 6 | 0.160 |
Why?
| | Self Report | 1 | 2024 | 858 | 0.160 |
Why?
| | Psychosocial Support Systems | 1 | 2019 | 13 | 0.150 |
Why?
| | Aged, 80 and over | 5 | 2024 | 7899 | 0.150 |
Why?
| | Medicare | 2 | 2015 | 806 | 0.150 |
Why?
| | Data Accuracy | 1 | 2019 | 63 | 0.150 |
Why?
| | Family | 1 | 2023 | 677 | 0.150 |
Why?
| | Ethics Committees, Research | 1 | 2019 | 41 | 0.150 |
Why?
| | Research Support as Topic | 1 | 2019 | 81 | 0.150 |
Why?
| | Prospective Studies | 4 | 2024 | 7749 | 0.150 |
Why?
| | Viremia | 1 | 2019 | 149 | 0.150 |
Why?
| | Home Infusion Therapy | 1 | 2018 | 4 | 0.150 |
Why?
| | Motion Pictures | 1 | 2019 | 20 | 0.150 |
Why?
| | Biomarkers | 2 | 2023 | 4175 | 0.140 |
Why?
| | Device Removal | 1 | 2020 | 140 | 0.140 |
Why?
| | Warfarin | 2 | 2021 | 153 | 0.140 |
Why?
| | Outpatients | 2 | 2023 | 418 | 0.140 |
Why?
| | Chronic Disease | 3 | 2022 | 1811 | 0.140 |
Why?
| | Immunocompromised Host | 1 | 2019 | 201 | 0.140 |
Why?
| | Nurse Practitioners | 2 | 2019 | 140 | 0.140 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 95 | 0.140 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 907 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2019 | 169 | 0.130 |
Why?
| | Spouses | 1 | 2018 | 108 | 0.130 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1536 | 0.130 |
Why?
| | Research Personnel | 1 | 2019 | 177 | 0.130 |
Why?
| | Diphenoxylate | 1 | 2016 | 5 | 0.130 |
Why?
| | Organ Transplantation | 1 | 2020 | 252 | 0.130 |
Why?
| | Antidiarrheals | 1 | 2016 | 14 | 0.130 |
Why?
| | Loperamide | 1 | 2016 | 12 | 0.130 |
Why?
| | Atropine | 1 | 2016 | 36 | 0.130 |
Why?
| | Periodicals as Topic | 1 | 2019 | 197 | 0.130 |
Why?
| | Nursing Assessment | 1 | 2017 | 57 | 0.130 |
Why?
| | Pressure Ulcer | 1 | 2017 | 45 | 0.130 |
Why?
| | Terminally Ill | 1 | 2016 | 37 | 0.130 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 284 | 0.130 |
Why?
| | Voltage-Gated Sodium Channel Blockers | 1 | 2016 | 6 | 0.130 |
Why?
| | Patient Care Management | 1 | 2016 | 55 | 0.120 |
Why?
| | Cause of Death | 1 | 2018 | 441 | 0.120 |
Why?
| | Follow-Up Studies | 6 | 2024 | 5194 | 0.120 |
Why?
| | Chromatography, Gas | 1 | 2016 | 33 | 0.120 |
Why?
| | Atrial Fibrillation | 1 | 2021 | 384 | 0.120 |
Why?
| | Consumer Health Information | 1 | 2016 | 49 | 0.120 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2016 | 55 | 0.120 |
Why?
| | Gastrointestinal Agents | 1 | 2016 | 66 | 0.120 |
Why?
| | Defibrillators, Implantable | 2 | 2016 | 306 | 0.120 |
Why?
| | Advanced Practice Nursing | 1 | 2016 | 37 | 0.120 |
Why?
| | Prosthesis Design | 2 | 2016 | 338 | 0.120 |
Why?
| | Health Policy | 2 | 2020 | 380 | 0.120 |
Why?
| | Truth Disclosure | 1 | 2016 | 46 | 0.120 |
Why?
| | Mortality | 1 | 2018 | 359 | 0.120 |
Why?
| | Hospices | 1 | 2016 | 88 | 0.120 |
Why?
| | Canada | 1 | 2017 | 419 | 0.120 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 337 | 0.120 |
Why?
| | Social Security | 1 | 2015 | 5 | 0.120 |
Why?
| | Medical Indigency | 1 | 2015 | 12 | 0.120 |
Why?
| | Referral and Consultation | 1 | 2021 | 794 | 0.120 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 197 | 0.120 |
Why?
| | Sex Distribution | 1 | 2016 | 381 | 0.120 |
Why?
| | Diagnosis-Related Groups | 1 | 2015 | 32 | 0.120 |
Why?
| | Drug Combinations | 1 | 2016 | 365 | 0.120 |
Why?
| | Uncertainty | 1 | 2016 | 136 | 0.120 |
Why?
| | Patient Care Planning | 1 | 2016 | 153 | 0.120 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 228 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3336 | 0.110 |
Why?
| | Patient Selection | 1 | 2019 | 684 | 0.110 |
Why?
| | Multimedia | 1 | 2014 | 12 | 0.110 |
Why?
| | Factor X | 1 | 2014 | 27 | 0.110 |
Why?
| | Fee-for-Service Plans | 1 | 2015 | 88 | 0.110 |
Why?
| | Workload | 1 | 2016 | 164 | 0.110 |
Why?
| | Health Care Costs | 1 | 2018 | 418 | 0.110 |
Why?
| | Assisted Circulation | 1 | 2014 | 25 | 0.110 |
Why?
| | Nurse's Role | 1 | 2016 | 167 | 0.110 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 101 | 0.110 |
Why?
| | Central Nervous System Stimulants | 1 | 2016 | 177 | 0.110 |
Why?
| | Treatment Refusal | 1 | 2015 | 96 | 0.110 |
Why?
| | Family Relations | 1 | 2015 | 90 | 0.110 |
Why?
| | Needs Assessment | 1 | 2016 | 384 | 0.110 |
Why?
| | Disease Progression | 2 | 2025 | 2791 | 0.100 |
Why?
| | Sex Factors | 2 | 2016 | 2051 | 0.100 |
Why?
| | Risk | 1 | 2016 | 903 | 0.100 |
Why?
| | Patient Discharge | 2 | 2022 | 930 | 0.100 |
Why?
| | Population Surveillance | 1 | 2017 | 479 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1052 | 0.100 |
Why?
| | Prognosis | 5 | 2024 | 4060 | 0.100 |
Why?
| | Cooperative Behavior | 1 | 2016 | 455 | 0.100 |
Why?
| | Heparin | 1 | 2014 | 258 | 0.100 |
Why?
| | Length of Stay | 2 | 2017 | 1259 | 0.100 |
Why?
| | Mass Screening | 1 | 2021 | 1300 | 0.100 |
Why?
| | Cohort Studies | 1 | 2023 | 5789 | 0.090 |
Why?
| | Antibodies | 1 | 2014 | 411 | 0.090 |
Why?
| | Program Evaluation | 1 | 2016 | 919 | 0.090 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 566 | 0.090 |
Why?
| | Pain Management | 1 | 2016 | 395 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2898 | 0.090 |
Why?
| | Acute Disease | 1 | 2014 | 1010 | 0.090 |
Why?
| | Immunosuppressive Agents | 1 | 2016 | 854 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1328 | 0.090 |
Why?
| | Pilot Projects | 1 | 2016 | 1815 | 0.080 |
Why?
| | Health Behavior | 1 | 2016 | 783 | 0.080 |
Why?
| | Time Factors | 4 | 2024 | 6944 | 0.080 |
Why?
| | Motivation | 1 | 2015 | 599 | 0.080 |
Why?
| | Frail Elderly | 2 | 2024 | 132 | 0.080 |
Why?
| | Internet | 1 | 2014 | 682 | 0.080 |
Why?
| | Comorbidity | 3 | 2020 | 1658 | 0.080 |
Why?
| | Prevalence | 1 | 2016 | 2780 | 0.080 |
Why?
| | Attitude of Health Personnel | 1 | 2016 | 1175 | 0.070 |
Why?
| | Incidence | 1 | 2014 | 2782 | 0.070 |
Why?
| | Bayes Theorem | 2 | 2019 | 415 | 0.060 |
Why?
| | Colorado | 3 | 2025 | 4597 | 0.060 |
Why?
| | Academic Medical Centers | 2 | 2020 | 527 | 0.060 |
Why?
| | Disease Management | 2 | 2022 | 628 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2760 | 0.060 |
Why?
| | Postoperative Complications | 3 | 2024 | 2813 | 0.050 |
Why?
| | Benzodiazepines | 1 | 2025 | 162 | 0.050 |
Why?
| | Michigan | 1 | 2024 | 131 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5645 | 0.050 |
Why?
| | Shock, Cardiogenic | 1 | 2024 | 59 | 0.050 |
Why?
| | Congresses as Topic | 1 | 2025 | 223 | 0.050 |
Why?
| | Cannabinoids | 1 | 2025 | 178 | 0.050 |
Why?
| | Information Systems | 1 | 2023 | 60 | 0.050 |
Why?
| | Young Adult | 2 | 2016 | 13646 | 0.050 |
Why?
| | Comprehension | 1 | 2024 | 182 | 0.050 |
Why?
| | Patient Care | 1 | 2023 | 117 | 0.050 |
Why?
| | Death | 1 | 2022 | 124 | 0.040 |
Why?
| | Consensus | 1 | 2024 | 545 | 0.040 |
Why?
| | Self Care | 1 | 2024 | 392 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 218 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 35 | 0.040 |
Why?
| | Role | 1 | 2020 | 30 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3278 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2024 | 690 | 0.040 |
Why?
| | Pharmacogenomic Testing | 1 | 2020 | 61 | 0.040 |
Why?
| | Hospitals, Community | 1 | 2020 | 58 | 0.040 |
Why?
| | Thromboembolism | 1 | 2021 | 118 | 0.040 |
Why?
| | Social Responsibility | 1 | 2020 | 52 | 0.040 |
Why?
| | Income | 1 | 2020 | 198 | 0.040 |
Why?
| | Contraindications, Procedure | 1 | 2019 | 12 | 0.040 |
Why?
| | Contracts | 1 | 2019 | 11 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 177 | 0.040 |
Why?
| | Visual Analog Scale | 1 | 2019 | 35 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2020 | 167 | 0.040 |
Why?
| | Self Efficacy | 1 | 2022 | 404 | 0.040 |
Why?
| | International Cooperation | 1 | 2019 | 195 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 323 | 0.040 |
Why?
| | Survival | 1 | 2018 | 39 | 0.040 |
Why?
| | Administration, Oral | 1 | 2021 | 802 | 0.040 |
Why?
| | Walk Test | 1 | 2018 | 79 | 0.030 |
Why?
| | Health Status | 1 | 2023 | 820 | 0.030 |
Why?
| | Equipment Design | 1 | 2019 | 525 | 0.030 |
Why?
| | Viral Load | 1 | 2019 | 498 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 363 | 0.030 |
Why?
| | ROC Curve | 1 | 2019 | 589 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 416 | 0.030 |
Why?
| | Intraoperative Care | 1 | 2017 | 63 | 0.030 |
Why?
| | Health Surveys | 1 | 2019 | 511 | 0.030 |
Why?
| | Adolescent | 1 | 2016 | 22027 | 0.030 |
Why?
| | Social Determinants of Health | 1 | 2020 | 273 | 0.030 |
Why?
| | Nurses | 1 | 2019 | 182 | 0.030 |
Why?
| | Hemorrhage | 1 | 2021 | 760 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1491 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 280 | 0.030 |
Why?
| | Life Change Events | 1 | 2016 | 151 | 0.030 |
Why?
| | Video Recording | 1 | 2016 | 197 | 0.030 |
Why?
| | Societies, Medical | 1 | 2019 | 852 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 803 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1031 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2019 | 746 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2018 | 584 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1320 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1441 | 0.030 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 622 | 0.020 |
Why?
| | Stroke | 1 | 2021 | 1158 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2016 | 645 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1763 | 0.020 |
Why?
| | Telemedicine | 1 | 2020 | 886 | 0.020 |
Why?
| | Body Mass Index | 1 | 2019 | 2374 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 1076 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 1220 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 2019 | 1940 | 0.020 |
Why?
| | Child | 1 | 2022 | 22313 | 0.010 |
Why?
|
|
McIlvennan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|